CompletedNCT03981289
Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)
Studying Limb-girdle muscular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Virginia Commonwealth University
- Principal Investigator
- Nicholas Johnson, MD, MDVirginia Commonwealth University
- Enrollment
- 116 enrolled
- Eligibility
- 4-65 years · All sexes
- Timeline
- 2019 – 2025
Study locations (10)
- University of California Irvine, Irvine, California, United States
- The University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
- University of Iowa, Iowa City, Iowa, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Kennedy Krieger Institute, Baltimore, Maryland, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- Virginia Commonwealth University, Richmond, Virginia, United States
- John Walton Muscular Dystrophy Research Centre (Newcastle Upon Tyne), Newcastle, United Kingdom
Collaborators
Newcastle University · Nationwide Children's Hospital · Washington University School of Medicine · University of Iowa · University of Minnesota · University of California, Irvine · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · University of Colorado, Denver · University of Kansas Medical Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03981289 on ClinicalTrials.govOther trials for Limb-girdle muscular dystrophy
Additional recruiting or active studies for the same condition.